Browsing by Subject "Immune checkpoint inhibitors"

Now showing items 1-3 of 3

Case report: Reinitiating pembrolizumab treatment after small bowel perforation

Beck T.; Kudinov A.; Dulaimi E.; Boumber Y. (2019)

© 2019 The Author(s). Background: Immune checkpoint inhibitors (ICIs) have emerged as paradigm shifting treatment options for a number of cancers. Six antibodies targeting the immune checkpoint proteins programmed cell ...
Current trends in cancer immunotherapy

Filin I.Y.; Solovyeva V.V.; Kitaeva K.V.; Rutland C.S.; Rizvanov A.A. (2020)

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. The search for an effective drug to treat oncological diseases, which have become the main scourge of mankind, has generated a lot of methods for studying this ...
Mouse tumor models for advanced cancer immunotherapy

Chulpanova D.S.; Kitaeva K.V.; Rutland C.S.; Rizvanov A.A.; Solovyeva V.V. (2020)

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Recent advances in the development of new methods of cancer immunotherapy require the production of complex cancer animal models that reliably reflect the complexity ...

Now showing items 1-3 of 3

Search DSpace